JDP, RAC must know all this.
But IIRC RAC has never mentioned that FTO inhibition significantly decreases HCM viability when dosed with cardiotoxic agents.
To do so would provoke discussion about Zan's CP MOA, which is a taboo subject.
JDP, RAC must know all this.But IIRC RAC has never mentioned...
Add RAC (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.49 |
Change
-0.060(3.87%) |
Mkt cap ! $249.1M | |||
| Open | High | Low | Value | Volume |
| $1.56 | $1.56 | $1.47 | $158.3K | 104.3K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 19999 | $1.49 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.52 | 2952 | 1 |
View Market Depth
| Last trade - 16.10pm 20/05/2024 (20 minute delay) ? |
|
|||||
|
Last
$1.50 |
Change
-0.060 ( 1.64 %) |
||||
| Open | High | Low | Volume | ||
| $1.57 | $1.57 | $1.47 | 10791 | ||
| Last updated 15.56pm 20/05/2024 ? | |||||
| RAC (ASX) Chart |